Arteriosclerosis and Thrombosis, Vol 14, 869-873, Copyright © 1994 by American Heart Association

ARTICLES

The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity

DN Nevin, JD Brunzell and SS Deeb
Department of Medicine, University of Washington, Seattle 98195.

Familial combined hyperlipidemia (FCHL) is an oligogenic disorder, with family members having elevated apolipoprotein B-100 levels and either elevated plasma cholesterol or triglyceride levels or both. Obligate heterozygous parents of children with lipoprotein lipase (LPL) deficiency express a mild FCHL phenotype. Of patients with FCHL, 36% have diminished postheparin LPL activity and mass values that are comparable with those of obligate heterozygotes for LPL deficiency. It is hypothesized that heterozygosity for mutations in the LPL gene could contribute to FCHL in this subset of patients. Single-strand conformation polymorphism (SSCP) analysis, direct DNA sequencing, and Southern blot analysis were used to examine exons 1 through 9 and exon- intron junctions of the LPL gene in 20 patients with FCHL and low LPL activity and mass. One subject had a substitution (GAC-->AAC) in exon 2, changing Asp9 to Asn. Two subjects had a previously undescribed "silent" substitution (GTG-->GTA) in exon 3 at Val108. Three patients had a premature termination at codon 447 in exon 9 resulting in truncation of the mature protein by two amino acids. In addition to SSCP analysis, exons 4, 5, and 6, where almost all mutations in LPL- deficient patients have been found, were sequenced and no additional mutations were found. Southern blot analysis of the LPL gene revealed one subject with heterozygous loss of an EcoRI site but without an abnormality in Stu I restriction fragments; this mutation is therefore unlikely to be functionally significant. The substitutions identified at codons 9 and 447 have previously been found not to affect lipolytic activity when expressed in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				H. Wang and R. H. Eckel Lipoprotein lipase: from gene to obesity Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E271 - E288. [Abstract] [Full Text] [PDF]

				S. Karkkainen, T. Helio, P. Jaaskelainen, R. Miettinen, P. Tuomainen, K. Ylitalo, M. Kaartinen, E. Reissell, L. Toivonen, M. S. Nieminen, et al. Two novel mutations in the {beta}-myosin heavy chain gene associated with dilated cardiomyopathy Eur J Heart Fail, December 1, 2004; 6(7): 861 - 868. [Abstract] [Full Text] [PDF]

				S. Karkkainen, T. Helio, R. Miettinen, P. Tuomainen, P. Peltola, J. Rummukainen, K. Ylitalo, M. Kaartinen, J. Kuusisto, L. Toivonen, et al. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy Eur. Heart J., May 2, 2004; 25(10): 885 - 893. [Abstract] [Full Text] [PDF]

				B. E. Aouizerat, H. Allayee, R. M. Cantor, G. M. Dallinga-Thie, C. D. Lanning, T. W. A. de Bruin, A. J. Lusis, and J. I. Rotter Linkage of a Candidate Gene Locus to Familial Combined Hyperlipidemia : Lecithin:Cholesterol Acyltransferase on 16q Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2730 - 2736. [Abstract] [Full Text] [PDF]

				O.-P. Pitkanen, P. Nuutila, O. T. Raitakari, K. Porkka, H. Iida, I. Nuotio, T. Ronnemaa, J. Viikari, M.-R. Taskinen, C. Ehnholm, et al. Coronary Flow Reserve in Young Men With Familial Combined Hyperlipidemia Circulation, April 6, 1999; 99(13): 1678 - 1684. [Abstract] [Full Text] [PDF]

				P. Jaaskelainen, M. Soranta, R. Miettinen, L. Saarinen, J. Pihlajamaki, K. Silvennoinen, T. Tikanoja, M. Laakso, and J. Kuusisto The cardiac {beta}-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1709 - 1716. [Abstract] [Full Text] [PDF]

				L. Karjalainen, J. Pihlajamaki, P. Karhapaa, and M. Laakso Impaired Insulin-Stimulated Glucose Oxidation and Free Fatty Acid Suppression in Patients with Familial Combined Hyperlipidemia : A Precursor Defect for Dyslipidemia? Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1548 - 1553. [Abstract] [Full Text] [PDF]

				S. Reynisdottir, B. Angelin, D. Langin, H. Lithell, M. Eriksson, C. Holm, and P. Arner Adipose Tissue Lipoprotein Lipase and Hormone-Sensitive Lipase : Contrasting Findings in Familial Combined Hyperlipidemia and Insulin Resistance Syndrome Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2287 - 2292. [Abstract] [Full Text]

				J. Pihlajamaki, J. Rissanen, S. Heikkinen, L. Karjalainen, and M. Laakso Codon 54 Polymorphism of the Human Intestinal Fatty Acid Binding Protein 2 Gene Is Associated With Dyslipidemias But Not With Insulin Resistance in Patients With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1039 - 1044. [Abstract] [Full Text]

				P. Pajukanta, K. V.K. Porkka, M. Antikainen, M.-R. Taskinen, M. Perola, S. Murtomaki-Repo, S. Ehnholm, I. Nuotio, L. Suurinkeroinen, A.-T. Lahdenkari, et al. No Evidence of Linkage Between Familial Combined Hyperlipidemia and Genes Encoding Lipolytic Enzymes in Finnish Families Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 841 - 850. [Abstract] [Full Text]

				T. J. Aitman, I. F. Godsland, B. Farren, D. Crook, H. J. Wong, and J. Scott Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 748 - 754. [Abstract] [Full Text]

				F. Mailly, Y. Tugrul, P. W. A. Reymer, T. Bruin, M. Seed, B. F. Groenemeyer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, et al. A Common Variant in the Gene for Lipoprotein Lipase (Asp9->Asn) : Functional Implications and Prevalence in Normal and Hyperlipidemic Subjects Arterioscler Thromb Vasc Biol, April 1, 1995; 15(4): 468 - 478. [Abstract] [Full Text]